Seroepidemiology of HTLV-I/II in Argentina: An Overview
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
In this report, the results of seroepidemiologic studies of human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II) infections in different population groups in Argentina have been compiled. The studies have shown a high prevalence of HTLV-I/II infection in blood donors in the provinces in the north of Argentina (1.0% in Jujuy, 0.7% in Salta, and 0.6% in Formosa) and a low prevalence in the provinces in the central region of the country (≤0.1%). High rates of HTLV-I (0.45%–2.78%) and HTLV-II (2.78%–21.9%) infections have been documented in Native Indian groups and have highlighted the importance of sexual and mother-to-child transmission of the viruses. The presence of HTLV-I/II antibodies in HIV-infected individuals indicates that both viruses are circulating in certain high-risk population groups. HTLV-I/II was detected in intravenous drug users (2.56%–21.7%), homosexual men (0.5–1.33%), prostitutes (0.8%), and hemophiliacs (2.8%). In conclusion, HTLV-I/II infection is circulating in low- and high-risk populations in Argentina, and these findings would support the view that selective screening for HTLV-I/II should be implemented to reduce the spread of infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yoshida, M., Miyoshi, I., & Hinuma, Y. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.6.2031 · Cited by 2,169 · cited 1×
“HTLV-I is the causative agent of ATLL and tropical spastic paraparesis/HTLV-I–associated myelopathy (TSP/HAM), a chronic demyelinating neurologic disorder.(4,5) In addition, it has been shown that HTLV-I is associated with a range of other inflammatory diseases.”
BackgroundManns, A., & Blattner, W. A. (1991) · Transfusion · doi:10.1046/j.1537-2995.1991.31191096189.x · Cited by 174 · cited 4×
“Infection with HTLV-I/II has been reported in a number of Amerindian communities from various geographic regions of the Americas.(49,50) In Argentina, several studies have also shown a high rate of HTLV-I and HTLV-II infections among such populations.”
BackgroundInfluential
Cited by
Epidemiological Aspects and World Distribution of HTLV-1 Infection
Gessain, A., & Cassar, O. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00388 · Cited by 1,428
“2% depending on the type and geographical location of the tested populations (Gastaldello et al., 2004; Trenchi et al., 2007; Berini et al., 2010).”
BackgroundGlobal epidemiology of HTLV-I infection and associated diseases
Proietti, F. A., Carneiro-Proietti, A. B. F., Catalan-Soares, B. C., & Murphy, E. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208968 · Cited by 1,008
Preventive and Therapeutic Strategies for Bovine Leukemia Virus: Lessons for HTLV
Rodríguez, S. M., Florins, A., Gillet, N., De Brogniez, A., Sánchez-Alcaraz, M. T., Boxus, M., Boulanger, F., Gutiérrez, G., Trono, K., Alvarez, I., et al. (2011) · Viruses · doi:10.3390/v3071210 · Cited by 196
“rates are close to 2% [293–299].”
Martin, F., Fedina, A., Youshya, S., & Taylor, G. P. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.191239 · Cited by 70
HTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review
Bradshaw, D., & Taylor, G. P. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.881547 · Cited by 12
Metadata
- Authors
- Gastaldello, R., Hall, W. W., & Gallego, S.
- Venue
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2004-03
- Volume
- 35
- Issue
- 3
- Pages
- 301-308
- ISSN
- 1525-4135 (ISSN-L)
- OpenAlex
- W1982057555
- Cited by
- 36
- References
- 2
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Seroepidemiology of HTLV-I/II in Argentina: An Overview. https://app.cochat.ai/papers/10.1097/00126334-200403010-00012
- The paper
- Gastaldello, R., Hall, W. W., & Gallego, S. (2004). Seroepidemiology of HTLV-I/II in Argentina: An Overview. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/00126334-200403010-00012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.